High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab ; volume:22 ; number:1 ; day:20 ; month:10 ; year:2020 ; pages:1-9 ; date:12.2020
Arthritis Research & Therapy ; 22, Heft 1 (20.10.2020), 1-9, 12.2020
- Creator
-
Strand, Vibeke
Boklage, Susan H.
Kimura, Toshio
Joly, Florence
Boyapati, Anita
Msihid, Jérôme
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-020-02344-3
- URN
-
urn:nbn:de:101:1-2020120507591247867433
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Strand, Vibeke
- Boklage, Susan H.
- Kimura, Toshio
- Joly, Florence
- Boyapati, Anita
- Msihid, Jérôme
- SpringerLink (Online service)
Other Objects (12)
Refractory necrotizing scleritis successfully treated with adalimumab
Comparisons of treatment satisfaction and health-related quality of life in patients with rheumatoid arthritis treated with tofacitinib and adalimumab
7.4 Improvements in individual disease components are sustained with long-term adalimumab therapy for polyarticular Juvenile Idiopathic Arthritis
Bullous Pemphigoid Associated with Adalimumab Therapy in a Patient with Ulcerative Colitis
Duodenal Crohn’s disease successfully treated with adalimumab
IgA Nephropathy in a Patient Treated with Adalimumab
Improvements for Concurrent Haskell with Futures
Other Experiences with Computational Performance Improvements
Similar Improvements in Patient-Reported Outcomes Among Rheumatoid Arthritis Patients Treated with Two Different Doses of Methotrexate in Combination with Adalimumab: Results From the MUSICA Trial
Systemic sarcoidosis with bone marrow involvement responding to therapy with adalimumab: a case report
Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis
Distal esophageal involvement in Crohn disease: short treatment with adalimumab
Refractory necrotizing scleritis successfully treated with adalimumab
Comparisons of treatment satisfaction and health-related quality of life in patients with rheumatoid arthritis treated with tofacitinib and adalimumab
7.4 Improvements in individual disease components are sustained with long-term adalimumab therapy for polyarticular Juvenile Idiopathic Arthritis
Bullous Pemphigoid Associated with Adalimumab Therapy in a Patient with Ulcerative Colitis
Duodenal Crohn’s disease successfully treated with adalimumab
IgA Nephropathy in a Patient Treated with Adalimumab
Improvements for Concurrent Haskell with Futures
Other Experiences with Computational Performance Improvements
Similar Improvements in Patient-Reported Outcomes Among Rheumatoid Arthritis Patients Treated with Two Different Doses of Methotrexate in Combination with Adalimumab: Results From the MUSICA Trial
Systemic sarcoidosis with bone marrow involvement responding to therapy with adalimumab: a case report
Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis
Distal esophageal involvement in Crohn disease: short treatment with adalimumab
Refractory necrotizing scleritis successfully treated with adalimumab
Comparisons of treatment satisfaction and health-related quality of life in patients with rheumatoid arthritis treated with tofacitinib and adalimumab
7.4 Improvements in individual disease components are sustained with long-term adalimumab therapy for polyarticular Juvenile Idiopathic Arthritis
Bullous Pemphigoid Associated with Adalimumab Therapy in a Patient with Ulcerative Colitis
Duodenal Crohn’s disease successfully treated with adalimumab
IgA Nephropathy in a Patient Treated with Adalimumab
Improvements for Concurrent Haskell with Futures
Other Experiences with Computational Performance Improvements
Similar Improvements in Patient-Reported Outcomes Among Rheumatoid Arthritis Patients Treated with Two Different Doses of Methotrexate in Combination with Adalimumab: Results From the MUSICA Trial
Systemic sarcoidosis with bone marrow involvement responding to therapy with adalimumab: a case report
Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis